Items where Author is "Hawkins, NM"
Up a level |
Number of items: 58.
2017
Kimaro, GD;
Mfinanga, S;
Simms, V;
Kivuyo, S;
Bottomley, C;
Hawkins, N;
Harrison, TS;
Jaffar, S;
Guinness, L;
REMSTART trial team;
(2017)
The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
PloS one, 12 (2).
e0171917.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0171917
Saffioti, F;
Gurusamy, KS;
Hawkins, N;
Toon, CD;
Tsochatzis, E;
Davidson, BR;
Thorburn, D;
(2017)
Pharmacological interventions for primary sclerosing cholangitis: an attempted networkmeta-analysis.
The Cochrane database of systematic reviews (3).
p. 91.
ISSN 1469-493X
DOI: https://doi.org/10.1002/14651858.CD011343.pub2
2016
Thompson, JC;
Quigley, JM;
Halfpenny, NJ;
Scott, DA;
Hawkins, NS;
(2016)
Importance and methods of searching for E-publications ahead of print in systematic reviews.
Evidence-based medicine.
ISSN 1356-5524
DOI: https://doi.org/10.1136/ebmed-2015-110374
Full text not available from this repository.
2015
Govan, L;
Wu, O;
Xin, Y;
Hutchinson, SJ;
Hawkins, N;
(2015)
Comparative effectiveness of antiviral treatment for hepatitis B.
European journal of gastroenterology & hepatology, 27 (8).
pp. 882-94.
ISSN 0954-691X
DOI: https://doi.org/10.1097/MEG.0000000000000376
Full text not available from this repository.
Woods, B;
Hawkins, N;
Mealing, S;
Sutton, A;
Abraham, WT;
Beshai, JF;
Klein, H;
Sculpher, M;
Plummer, CJ;
Cowie, MR;
(2015)
Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.
Heart (British Cardiac Society).
ISSN 1355-6037
DOI: https://doi.org/10.1136/heartjnl-2015-307634
2014
Fletcher, C;
Chuang-Stein, C;
Paget, MA;
Reid, C;
Hawkins, N;
(2014)
Subgroup analyses in cost-effectiveness analyses to support health technology assessments.
Pharmaceutical statistics, 13 (4).
pp. 265-74.
ISSN 1539-1604
DOI: https://doi.org/10.1002/pst.1626
Full text not available from this repository.
Laws, A;
Kendall, R;
Hawkins, N;
(2014)
A comparison of national guidelines for network meta-analysis.
Value in health, 17 (5).
pp. 642-54.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2014.06.001
Full text not available from this repository.
Lipton, JH;
Bryden, P;
Sidhu, MK;
Huang, H;
McGarry, LJ;
Lustgarten, S;
Mealing, S;
Woods, B;
Whelan, J;
Hawkins, N;
(2014)
Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors.
Leukemia research, 39 (1).
pp. 58-64.
ISSN 0145-2126
DOI: https://doi.org/10.1016/j.leukres.2014.10.005
Full text not available from this repository.
Mealing, S;
Ghement, I;
Hawkins, N;
Scott, DA;
Lescrauwaet, B;
Watt, M;
Thursz, M;
Lampertico, P;
Mantovani, L;
Morais, E;
+2 more...
Bregman, B;
Cucherat, M;
(2014)
The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis.
Systematic reviews, 3.
p. 21.
ISSN 2046-4053
DOI: https://doi.org/10.1186/2046-4053-3-21
Ortega, A;
Fraga, MD;
Alegre-del-Rey, EJ;
Puigventós-Latorre, F;
Porta, A;
Ventayol, P;
Tenias, JM;
Hawkins, NS;
Caldwell, DM;
(2014)
A checklist for critical appraisal of indirect comparisons.
International journal of clinical practice, 68.
pp. 1181-9.
ISSN 1368-5031
DOI: https://doi.org/10.1111/ijcp.12487
Full text not available from this repository.
Wong, CM;
Hawkins, NM;
Petrie, MC;
Jhund, PS;
Gardner, RS;
Ariti, CA;
Poppe, KK;
Earle, N;
Whalley, GA;
Squire, IB;
+3 more...
Doughty, RN;
McMurray, JJ;
on behalf of the MAGGIC Investigators;
(2014)
Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC).
European heart journal.
ISSN 0195-668X
DOI: https://doi.org/10.1093/eurheartj/ehu216
Full text not available from this repository.
2013
Ali, S;
Mealing, S;
Hawkins, N;
Lescrauwaet, B;
Bjork, S;
Mantovani, L;
Lampertico, P;
(2013)
The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients.
BMJ open, 3 (1).
ISSN 2044-6055
DOI: https://doi.org/10.1136/bmjopen-2012-001309
Goring, S;
Hawkins, N;
Wygant, G;
Roudaut, M;
Townsend, R;
Wood, I;
Barnett, AH;
(2013)
Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: A systematic review and network meta-analysis.
Diabetes, obesity & metabolism, 16.
pp. 433-442.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.12239
Full text not available from this repository.
Khan, N;
Shah, D;
Tongbram, V;
Verdian, L;
Hawkins, N;
(2013)
The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis.
Current medical research and opinion, 29 (8).
pp. 1001-13.
ISSN 0300-7995
DOI: https://doi.org/10.1185/03007995.2013.803461
Full text not available from this repository.
2012
Boden, LL;
Handel, II;
Hawkins, NN;
Houston, FF;
Fryer, HH;
Kao, RR;
(2012)
An economic evaluation of preclinical testing strategies compared to the compulsory scrapie flock scheme in the control of classical scrapie.
PloS one, 7.
e32884-e32884.
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0032884
Dewilde, S;
Hawkins, N;
(2012)
Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention.
Journal of clinical epidemiology, 65 (8).
pp. 835-45.
ISSN 0895-4356
DOI: https://doi.org/10.1016/j.jclinepi.2012.01.019
Full text not available from this repository.
Hawkins, N;
Laws, A;
Kendall, R;
(2012)
Comparison of National Guidelines for Indirect Network Meta-Analysis.
p. 2012.
http://researchonline.lshtm.ac.uk/id/eprint/2534560
Full text not available from this repository.
Woods, B;
Hawkins, N;
Dunlop, W;
O'Toole, A;
Bramham-Jones, S;
(2012)
Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: A cost-utility analysis.
Value in health, 15 (5).
pp. 759-70.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2012.03.1389
Full text not available from this repository.
2011
Bujkiewicz, S;
Jones, HE;
Lai, MC;
Cooper, NJ;
Hawkins, N;
Squires, H;
Abrams, KR;
Spiegelhalter, DJ;
Sutton, AJ;
(2011)
Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.
Value in health, 14 (5).
pp. 768-76.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2010.12.002
Gross, JL;
Kramer, CK;
Leitão, CB;
Hawkins, N;
Viana, LV;
Schaan, BD;
Pinto, LC;
Rodrigues, TC;
Azevedo, MJ;
(2011)
Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: A network meta-analysis.
Annals of internal medicine, 154.
pp. 672-679.
ISSN 0003-4819
DOI: https://doi.org/10.7326/0003-4819-154-10-201105170-00007
Full text not available from this repository.
Hawkins, N;
Richardson, G;
Sutton, AJ;
Cooper, NJ;
Griffiths, C;
Rogers, A;
Bower, P;
(2011)
Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach.
Health economics, 756.
pp. 742-756.
ISSN 1057-9230
DOI: https://doi.org/10.1002/hec.1741
Full text not available from this repository.
Hawkins, N;
Richardson, G;
Sutton, AJ;
Cooper, NJ;
Griffiths, C;
Rogers, A;
Bower, P;
(2011)
SURROGATES , META ‐ ANALYSIS AND COST ‐ EFFECTIVENESS MODELLING : A COMBINED ANALYTIC APPROACH.
DOI: https://doi.org/10.1002/hec
Full text not available from this repository.
Hawkins, N;
Scott, DA;
(2011)
REIMBURSEMENT AND VALUE-BASED PRICING : STRATIFIED COST-EFFECTIVENESS ANALYSIS MAY NOT BE THE LAST WORD.
Health economics, 20 (6).
pp. 688-98.
ISSN 1057-9230
DOI: https://doi.org/10.1002/hec.1625
Full text not available from this repository.
Hoaglin, DC;
Hawkins, N;
Jansen, JP;
Scott, DA;
Itzler, R;
Cappelleri, JC;
Boersma, C;
Thompson, D;
Larholt, KM;
Diaz, M;
+1 more...
Barrett, A;
(2011)
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
Value in health, 14 (4).
pp. 429-37.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2011.01.011
Full text not available from this repository.
Jansen, JP;
Fleurence, R;
Devine, B;
Itzler, R;
Barrett, A;
Hawkins, N;
Lee, K;
Boersma, C;
Annemans, L;
Cappelleri, JC;
(2011)
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: Report of the ISPOR task force on indirect treatment comparisons good research practices: Part 1.
Value in health, 14 (4).
pp. 417-28.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2011.04.002
Full text not available from this repository.
Reich, K;
Burden, AD;
Eaton, JN;
Hawkins, NS;
(2011)
Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
The British journal of dermatology, 166.
pp. 179-88.
ISSN 0007-0963
DOI: https://doi.org/10.1111/j.1365-2133.2011.10583.x
Full text not available from this repository.
Woods, B;
Veenstra, D;
Hawkins, N;
(2011)
Prioritizing pharmacogenetic research: A value of information analysis of CYP2D6 testing to guide breast cancer treatment.
The Cochrane library, 14.
pp. 989-1001.
ISSN 1465-1858
DOI: https://doi.org/10.1016/j.jval.2011.05.048
Full text not available from this repository.
2010
Chambers, D;
Worthy, G;
Myers, L;
Weatherly, H;
Elliott, R;
Hawkins, N;
Sculpher, M;
Eastwood, A;
(2010)
Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review.
Surgical infections, 11.
pp. 455-462.
ISSN 1096-2964
DOI: https://doi.org/10.1089/sur.2009.055
Full text not available from this repository.
Hawkins, N;
Scott, DA;
(2010)
Placebo at Your Peril.
DOI: https://doi.org/10.1177/0272989X10362106
Full text not available from this repository.
Hawkins, N;
Scott, DA;
(2010)
Cost-effectiveness analysis: discount the placebo at your peril.
Medical decision making, 30.
pp. 536-43.
ISSN 0272-989X
DOI: https://doi.org/10.1177/0272989X10362106
Full text not available from this repository.
Hawkins, NS;
Cranny, Æ, G;
Chambers, Æ, D;
Myers, L;
Eastwood, Æ, A;
Sculpher, Æ, MJ;
Elliott, RA;
Weatherly, HLA;
Hawkins, NS;
Cranny, G;
+4 more...
Chambers, D;
Myers, L;
Eastwood, A;
Sculpher, MJ;
(2010)
An economic model for the prevention of MRSA infections after surgery: Non-glycopeptide or glycopeptide antibiotic prophylaxis?
The European journal of health economics, 11.
pp. 57-66.
ISSN 1618-7598
DOI: https://doi.org/10.1007/s10198-009-0175-0
Full text not available from this repository.
McKenna, C;
Hawkins, N;
Claxton, K;
McDaid, C;
Suekarran, S;
Light, K;
Chester, M;
Cleland, JGF;
Woolacott, N;
Sculpher, M;
(2010)
Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom.
International journal of technology assessment in health care, 26.
pp. 175-82.
ISSN 0266-4623
DOI: https://doi.org/10.1017/S0266462310000073
Full text not available from this repository.
Punekar, YS;
Hawkins, N;
(2010)
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis.
The European journal of health economics : HEPAC : health economics in prevention and care, 11.
pp. 67-76.
DOI: https://doi.org/10.1007/s10198-009-0199-5; 10.1007/s10198-009-0199-5
Full text not available from this repository.
Punekar, YS;
Sunderland, T;
Hawkins, N;
Lindsay, J;
(2010)
Cost-effectiveness of scheduled maintenance treatment with infliximab for pediatric Crohn's disease.
Value in health, 13.
pp. 188-195.
ISSN 1098-3015
DOI: https://doi.org/10.1111/j.1524-4733.2009.00658.x
Full text not available from this repository.
Woods, BS;
Hawkins, N;
Scott, DA;
(2010)
Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial.
BMC medical research methodology, 10.
p. 54.
ISSN 1471-2288
DOI: https://doi.org/10.1186/1471-2288-10-54
2009
Hawkins, N;
Scott, DA;
Woods, B;
(2009)
How far do you go? Efficient searching for indirect evidence.
Medical decision making, 29 (3).
pp. 273-81.
ISSN 0272-989X
DOI: https://doi.org/10.1177/0272989X08330120
Full text not available from this repository.
Hawkins, N;
Scott, DA;
Woods, BS;
Thatcher, N;
(2009)
No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data.
Value in health, 12 (6).
pp. 996-1003.
ISSN 1098-3015
DOI: https://doi.org/10.1111/j.1524-4733.2009.00541.x
Full text not available from this repository.
McKenna, C;
Palmer, S;
Rodgers, M;
Chambers, D;
Hawkins, N;
Golder, S;
van Hout, S;
Pepper, C;
Todd, D;
Woolacott, N;
(2009)
Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom.
Heart (British Cardiac Society), 95.
pp. 542-549.
ISSN 1355-6037
DOI: https://doi.org/10.1136/hrt.2008.147165
Full text not available from this repository.
2008
Barbieri, M;
Hawkins, N;
Sculpher, M;
(2008)
Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies.
Value in health, 12 (2).
pp. 193-201.
ISSN 1098-3015
DOI: https://doi.org/10.1111/j.1524-4733.2008.00441.x
Full text not available from this repository.
Cranny, G;
Elliott, R;
Weatherly, H;
Chambers, D;
Hawkins, N;
Myers, L;
Sculpher, M;
Eastwood, A;
(2008)
A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.
Health technology assessment (Winchester, England), 12 (1).
iii-iv, xi-xii, 1-147.
ISSN 1366-5278
DOI: https://doi.org/10.3310/hta12010
Ryan, M;
Griffin, S;
Chitah, B;
Walker, AS;
Mulenga, V;
Kalolo, D;
Hawkins, N;
Merry, C;
Barry, MG;
Chintu, C;
+2 more...
Sculpher, MJ;
Gibb, DM;
(2008)
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
AIDS (London, England), 22.
pp. 749-57.
ISSN 0269-9370
DOI: https://doi.org/10.1097/QAD.0b013e3282f43519
Full text not available from this repository.
2007
Bravo Vergel, Y;
Hawkins, NS;
Claxton, K;
Asseburg, C;
Palmer, S;
Woolacott, N;
Bruce, IN;
Sculpher, MJ;
(2007)
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.
Rheumatology (Oxford, England), 46.
pp. 1729-35.
ISSN 1462-0324
DOI: https://doi.org/10.1093/rheumatology/kem221
Full text not available from this repository.
Hawkins, N;
Claxton, K;
Light, K;
(2007)
Etanercept and Infliximab for the Treatment of Psoriatic Arthritis.
http://researchonline.lshtm.ac.uk/id/eprint/2534612
Full text not available from this repository.
Thomas, M;
Care, P;
Medicine, R;
Doull, I;
Price, D;
Thomas, M;
Hawkins, N;
Stamuli, E;
Tabberer, M;
Gosden, T;
+1 more...
Rudge, H;
(2007)
Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
Current medical research and opinion, 23.
pp. 1147-59.
ISSN 0300-7995
DOI: https://doi.org/10.1185/030079907X187982
Full text not available from this repository.
2006
Griffin, S;
Claxton, K;
Hawkins, N;
Sculpher, M;
(2006)
Probabilistic analysis and computationally expensive models: Necessary and required?
Value in health, 9.
pp. 244-252.
ISSN 1098-3015
DOI: https://doi.org/10.1111/j.1524-4733.2006.00107.x
Full text not available from this repository.
Richardson, G;
Hawkins, N;
McCarthy, CJ;
Mills, PM;
Pullen, R;
Roberts, C;
Silman, A;
Oldham, JA;
(2006)
Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis.
International journal of technology assessment in health care, 22 (1).
pp. 84-9.
ISSN 0266-4623
http://researchonline.lshtm.ac.uk/id/eprint/2534599
Full text not available from this repository.
Woolacott, N;
Bravo Vergel, Y;
Hawkins, N;
Kainth, A;
Khadjesari, Z;
Misso, K;
Light, K;
Asseburg, C;
Palmer, S;
Claxton, K;
+3 more...
Bruce, I;
Sculpher, M;
Riemsma, R;
(2006)
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
Health technology assessment (Winchester, England), 10.
iii-iv, xiii-xvi, 1-239.
ISSN 1366-5278
http://researchonline.lshtm.ac.uk/id/eprint/2534859
Woolacott, N;
Hawkins, N;
Mason, A;
Al., E;
(2006)
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Health technology assessment (Winchester, England), 10.
1-233, i-iv.
ISSN 1366-5278
DOI: https://doi.org/10.3310/hta10460
2005
Hawkins, N;
Epstein, D;
Drummond, M;
Wilby, J;
(2005)
Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults :.
pp. 493-510.
http://researchonline.lshtm.ac.uk/id/eprint/2534563
Full text not available from this repository.
Hawkins, N;
Epstein, D;
Drummond, M;
Wilby, J;
Kainth, A;
Chadwick, D;
Sculpher, M;
(2005)
Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model.
Medical decision making, 25.
pp. 493-510.
ISSN 0272-989X
DOI: https://doi.org/10.1177/0272989X05280559
Full text not available from this repository.
Hawkins, N;
Sculpher, M;
Epstein, D;
(2005)
Cost-effectiveness analysis of treatments for chronic disease: using R to incorporate time dependency of treatment response.
Medical decision making, 25 (5).
pp. 511-9.
ISSN 0272-989X
DOI: https://doi.org/10.1177/0272989X05280562
Full text not available from this repository.
Manca, A;
Hawkins, N;
Sculpher, MJ;
(2005)
Estimating mean QALYs in trial-based cost-e ¡ ectiveness analysis : the importance of controlling for baseline utility.
pp. 487-496.
DOI: https://doi.org/10.1002/hec.944
Full text not available from this repository.
Wilby, J;
Kainth, A;
Hawkins, N;
Epstein, D;
McIntosh, H;
McDaid, C;
Mason, A;
Golder, S;
O'Meara, S;
Sculpher, M;
+2 more...
Drummond, M;
Forbes, C;
(2005)
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Health technology assessment (Winchester, England), 9.
1-157, iii-iv.
ISSN 1366-5278
DOI: 01-50-01 [pii]
2004
Jones, L;
Griffin, S;
Palmer, S;
Main, C;
Orton, V;
Sculpher, M;
Sudlow, C;
Henderson, R;
Hawkins, N;
Riemsma, R;
(2004)
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: A systematic review and economic evaluation.
Health technology assessment (Winchester, England), 8 (38).
iii-iv, 1-196.
ISSN 1366-5278
http://researchonline.lshtm.ac.uk/id/eprint/2545583
Jones, L;
Hawkins, N;
Westwood, M;
Wright, K;
Richardson, G;
Riemsma, R;
(2004)
Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer.
Health technology assessment (Winchester, England), 8 (5).
iii, xiii-xvi, 1-143.
ISSN 1366-5278
http://researchonline.lshtm.ac.uk/id/eprint/2534908
Main, C;
Palmer, S;
Griffin, S;
Jones, L;
Orton, V;
Sculpher, M;
Henderson, R;
Sudlow, C;
Hawkins, N;
Riemsma, R;
(2004)
Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.
Health technology assessment (Winchester, England), 8 (40).
iii-iv, xv-xvi, 1-141.
ISSN 1366-5278
http://researchonline.lshtm.ac.uk/id/eprint/2545420
McCarthy, CJ;
Mills, PM;
Pullen, R;
Richardson, G;
Hawkins, N;
Roberts, CR;
Silman, AJ;
Oldham, JA;
(2004)
Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: A randomised controlled trial and health economic analysis.
Health technology assessment (Winchester, England), 8.
p. 2015.
ISSN 1366-5278
DOI: https://doi.org/10.3310/hta8460
2003
Westwood, M;
Hawkins, N;
Riemsma, R;
(2003)
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of capecitabine ( Xeloda ® ) for locally advanced and / or metastatic breast cancer.
http://researchonline.lshtm.ac.uk/id/eprint/2535033
Full text not available from this repository.